血清PSA、PSAD预测前列腺癌骨转移的临床价值分析
本文关键词:血清PSA、PSAD预测前列腺癌骨转移的临床价值分析 出处:《新疆医科大学》2017年硕士论文 论文类型:学位论文
更多相关文章: 前列腺特异性抗原 前列腺特异性抗原密度 前列腺癌 骨转移
【摘要】:目的:探讨血清前列腺特异性抗原(PSA)及前列腺特异性抗原密度(PSAD)应用于预测前列腺癌骨转移的临床价值。方法:回顾性分析我院2010年1月-2016年10月经前列腺穿刺活检确诊的前列腺癌患者63例,均行核素骨扫描检查,根据检查结果分为前列腺骨转移组及前列腺癌非骨转移组,对两组患者的PSA及PSAD水平进行分析,得出PSA及PSAD与前列腺癌骨转移的关系。结果:前列腺癌骨转移组及非骨转移组的PSA及PSAD水平存在统计学差异。以PSA20ng/ml作为诊断标准预测前列腺癌骨转移,灵敏度为89.7%,特异度为76.5%,以血清PSAD0.4ng/(ml·cm3)作为诊断标准预测前列腺癌骨转移,灵敏度为86.2%,特异度为73.5%,两者的ROC曲线下面积分别为0.919和0.866,以血清PSA20ng/ml联合PSAD0.4 ng/(ml·cm3)作为标准预测临床前列腺癌骨转移,诊断的灵敏度为86.2%,特异度为85.3%。结论:PSA及PSAD均可应用于前列腺癌骨转移的预测,两者联合应用可提高前列腺癌骨转移的诊断价值,对于血清PSA20ng/ml联合PSAD0.4ng/(ml·cm3)的患者应高度怀疑骨转移的存在,积极进行骨扫描确定诊断。
[Abstract]:Objective: to study serum prostate specific antigen (PSA) and prostate specific antigen density (PSAD). Methods: 63 cases of prostate cancer diagnosed by prostate biopsy from January 2010 to 2016 were analyzed retrospectively. All patients were examined by bone radionuclide scan. According to the results, the patients were divided into two groups: bone metastasis group and non-bone metastasis group. The levels of PSA and PSAD in both groups were analyzed. The relationship between PSA and PSAD and bone metastasis of prostate cancer was obtained. The levels of PSA and PSAD in bone metastasis group and non-bone metastasis group were statistically different. PSA20ng/ml was used as diagnostic criterion to predict bone metastasis of prostate cancer. The sensitivity was 89. 7 and the specificity was 76. 5. Serum PSAD0.4ng/(ml 路cm 3 was used as diagnostic criteria for predicting bone metastasis of prostate cancer. The sensitivity was 86.2%. The specificity was 73.5 and the area under the ROC curve was 0.919 and 0.866, respectively. Serum PSA20ng/ml combined with PSAD0.4 ng/(ml 路cm 3 was used to predict bone metastasis of prostate cancer. The diagnostic sensitivity was 86.2%. Conclusion both PSAD and PSAD can be used to predict bone metastasis of prostate cancer, and the combination of them can improve the diagnostic value of bone metastasis of prostate cancer. For patients with serum PSA20ng/ml combined with PSAD0.4ng/(ml 路cm 3, bone metastasis should be highly suspected and bone scan should be actively performed to determine the diagnosis.
【学位授予单位】:新疆医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R737.25
【参考文献】
相关期刊论文 前10条
1 翁锡君;谢立平;郑祥义;汪朔;蔡柏森;项尖尖;尤启汉;;前列腺特异性抗原密度预测前列腺癌包膜侵犯的价值研究[J];中国全科医学;2016年20期
2 刘铭;苗娜;朱耀;顾成元;师晓莉;崔文丽;张巍;李巧新;;Vav3基因位点多态性与中国汉族人群前列腺癌发病风险的关联性[J];中华病理学杂志;2016年07期
3 张志鹏;刘明;陈敏;李春媚;王鑫;王萱;万奔;朱生才;王建业;;磁共振靶向前列腺穿刺活检对前列腺癌诊断的研究[J];中华泌尿外科杂志;2016年03期
4 王海涛;;去势抵抗性前列腺癌精准医学研究的探索[J];中国肿瘤临床;2015年17期
5 王野;高旭;杨庆;孙颖浩;;前列腺癌骨转移发生机制的研究进展[J];中华泌尿外科杂志;2015年09期
6 邵立钦;范锐;岳俊敏;牛俊豪;张昊;万久恺;王朝阳;;手术去势联合间歇性雄激素全阻断疗法治疗局部进展期前列腺癌的疗效[J];中国老年学杂志;2015年14期
7 叶杨;汪骏;秦超;华立新;;中晚期前列腺癌单药治疗与最大限度雄激素阻断疗法的疗效及副作用观察[J];现代泌尿外科杂志;2015年06期
8 叶定伟;朱耀;;中国前列腺癌的流行病学概述和启示[J];中华外科杂志;2015年04期
9 钱苏波;沈海波;曹奇峰;齐隽;;抗雄激素撤退治疗去势抵抗性前列腺癌的疗效分析[J];现代泌尿外科杂志;2015年01期
10 沈茜刚;周良平;彭卫军;毛健;张灵;姚之丰;程竞仪;刘晓航;丁建辉;岳磊;;背景抑制扩散加权成像与核素骨扫描在恶性肿瘤骨转移病变诊断中的对照研究[J];中国癌症杂志;2014年03期
,本文编号:1407319
本文链接:https://www.wllwen.com/shoufeilunwen/mpalunwen/1407319.html